| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $635K | +256.4% | — |
| R&D Expense | $1.0M | +238.4% | +118.3% |
| SG&A Expense | $1.1M | -6.4% | -4.0% |
| Operating Income | -$1.9M | -37.6% | -17.2% |
| Interest Expense | $30K | -19.1% | -80.1% |
| Pre-tax Income | -$809K | +41.3% | +46.6% |
| Net Income | -$1.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $194K | +279.5% | — |
| Inventory | $155K | +16.3% | — |
| Current Assets | $1.5M | +177.2% | +314.1% |
| Total Assets | $7.5M | +12.8% | +1070.6% |
| Current Liabilities | $15.0M | +3.3% | +82.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.5M | — | — |
| Financing Cash Flow | $1.7M | — | — |
| -55.5% |
| -26.8% |
| EPS (Diluted) | -$0.11 | -57.1% | +21.4% |
| $20.3M |
| +3.1% |
| +60.5% |
| Stockholders' Equity | -$13.5M | -6.8% | -14.0% |